My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Volumes jump at Relaxo Footwears counter
Mar 14,2017

Relaxo Footwears clocked volume of 16.86 lakh shares by 14:47 IST on BSE, a 783.55-times surge over two-week average daily volume of 2,152 shares. The stock rose 4.83% to Rs 465.50.

IST notched up volume of 64,000 shares, a 176.52-fold surge over two-week average daily volume of 362 shares. The stock was unchanged at Rs 790.

OCL India saw volume of 2.82 lakh shares, a 123.94-fold surge over two-week average daily volume of 2,277 shares. The stock rose 1.52% to Rs 920.

Polaris Consulting & Services clocked volume of 5.99 lakh shares, a 35.12-fold surge over two-week average daily volume of 17,000 shares. The stock rose 1.91% to Rs 184.25.

Metalyst Forgings saw volume of 29.66 lakh shares, a 32.28-fold rise over two-week average daily volume of 92,000 shares. The stock rose 3.99% to Rs 62.60.

Powered by Capital Market - Live News

Kalyani Forge drops on profit booking
Mar 14,2017

Meanwhile, the S&P BSE Sensex was up 505.29 points, or 1.75% to 29,451.52

On BSE, so far 1,455 shares were traded in the counter, compared with average daily volume of 1,674 shares in the past one quarter. The stock hit a high of Rs 409 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 375 so far during the day. The stock had hit a 52-week low of Rs 220.30 on 2 June 2016.

The stock had outperformed the market over the past 30 days till 10 March 2017, rising 34.72% compared with the 2.18% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 39.54% as against Sensexs 8.22% gain.

The small-cap companys equity capital is Rs 3.64 crore. Face value per share is Rs 10.

Kalyani Forges net profit surged 109.76% to Rs 1.72 crore on 3.25% rise in net sales to Rs 55.86 crore in Q3 December 2016 over Q3 December 2015.

Kalyani Forge is an engineering company with an expertise in metal forming. The company makes forged, machined and assembled products for a variety of customers in industries like automotive, construction, power generation, marine, railway, and industrial goods.

Powered by Capital Market - Live News

Sun Pharma jumps as USFDA to lift import alert on Mohali unit
Mar 14,2017

The announcement was made during trading hours today, 14 March 2017.

Meanwhile, the S&P BSE Sensex was up 514.35 points, or 1.78% to 29,460.58.

On the BSE, 10.36 lakh shares were traded in the counter so far, compared with average daily volumes of 3.82 lakh shares in the past one quarter. The stock had hit a high of Rs 728.45 and a low of Rs 678.10 so far during the day. The stock hit a 52-week high of Rs 876 on 14 March 2016. The stock hit a 52-week low of Rs 572.40 on 9 November 2016.

The stock had outperformed the market over the past one month till 10 March 2017, rising 4.08% compared with 2.18% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 1.57% as against Sensexs 8.22% rise.

The large-cap company has equity capital of Rs 239.93 crore. Face value per share is Re 1.

Sun Pharmaceuticals Industries (Sun Pharma) was informed by the US Food and Drug Administration (US FDA) that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the Official Action Initiated (OAI) status. This proposed action will clear the path for Sun Pharma to supply approved products from the Mohali facility to the US market, subject to normal US FDA regulatory requirements.

The Mohali facility was inherited by Sun Pharma as part of its acquisition of Ranbaxy Laboratories in 2015. The US FDA had taken action against the Mohali facility in 2013 when it ordered the facility to be fully subject to Ranbaxys Consent Decree of Permanent Injunction. Certain conditions of the consent decree will continue to be applicable to the Mohali facility.

This development illustrates Sun Pharmas commitment to work closely with the US FDA and strive for 100% cGMP compliance at its manufacturing facilities.

On a consolidated basis, Sun Pharmaceuticals Industries net profit declined 11.23% to Rs 1721.85 crore on 8.41% rise in net sales to Rs 7683.24 crore in Q3 December 2016 over Q3 December 2015.

Sun Pharma is the worlds fourth largest specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Gujarat Fluorochemicals gains on report of rejig
Mar 14,2017

Meanwhile, the S&P BSE Sensex was up 529.40 points, or 1.83% to 29,475.63.

On the BSE, 43,000 shares were traded in the counter so far, compared with average daily volumes of 25,608 shares in the past one quarter. The stock had hit a high of Rs 621 and a low of Rs 595.50 so far during the day. The stock hit a 52-week high of Rs 666.65 on 27 July 2016. The stock hit a 52-week low of Rs 451 on 9 November 2016.

The stock had outperformed the market over the past one month till 10 March 2017, rising 19.86% compared with 2.18% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 24.35% as against Sensexs 8.22% rise.

The mid-cap company has equity capital of Rs 10.99 crore. Face value per share is Re 1.

According to the media report, Gujarat Fluorochemicals plans to make its structure a simpler one. The focus will be on restructuring the chemical business and remove the holding company discount. As part of the strategy, the firm will demerge its chemicals business into a separate entity. Currently, the company has four verticalsn++chemicals, wind turbine manufacturing, wind farm, film exhibition.

On the financial front, the companys standalone specialty chemical business is valued at Rs 5000 crore, while its market capitalisation is seen at Rs 6500 crore, the report added.

On a consolidated basis, net profit of Gujarat Fluorochemicals declined 7.69% to Rs 73.38 crore on 16.79% rise in net sales to Rs 1790.21 crore in Q3 December 2016 over Q3 December 2015.

Gujarat Fluorochemicals, a part of the INOX Group of companies, makes fluoropolymers, fluoroelastomer, fluoroadditives, fluorospeciality chemicals, refrigerants and chemicals.

Powered by Capital Market - Live News

Fitch: Brexit: Now Comes the Hard Part
Mar 14,2017

The British government will soon provide formal notice of its intention to withdraw from the European Union, and, as contentious as the debate on Brexit has been to now, the period ahead promises to be even more combative, says Fitch Ratings in its latest Global Perspectives commentary.

The UK faces five primary challenges from the outset. Lack of full control over the negotiating agenda is the most important of these. While Prime Minister May has said a comprehensive free trade agreement with the EU is one of the governments objectives, some European leaders have suggested that post-exit trade arrangements can only be considered after the terms of exit have been agreed.

A related challenge will be settling the financial terms of the UKs departure from the EU, which is likely to be among the issues EU leaders seek to resolve up front. The UK will have a strong incentive to settle its exit bill quickly to preserve as much of the two-year negotiating period as possible for more difficult and important issues. But in so doing, it risks criticism at home of an early and unnecessary concession

The three remaining challenges are domestic. Scotland may seek a bespoke solution to allow continued access to the single market, raising the risk of a second independence referendum if its objectives are unmet. Beyond Scotland, there is certain to be plenty of open opposition to the governments negotiating strategies and priorities, exposing possible political pressure points that can be exploited by EU negotiators.

Finally, it will prove challenging for the government to manage expectations over a two-year period, and negotiating setbacks may be reflected in heightened financial market volatility. The biggest associated risk is a decided swing in public opinion toward a more negative view of Brexit, lending support for either a greater Parliamentary role in approving the final negotiated agreement or another opportunity for the electorate to formally express its view.

Powered by Capital Market - Live News

IL&FS Transportation advances after divestment of stake in Andhra Pradesh Expressway
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 461 points, or 1.59%, to 29,407.23

On BSE, so far 32,000 shares were traded in the counter, compared with average daily volume of 1.27 lakh shares in the past one quarter. The stock hit a high of Rs 104.90 and a low of Rs 101.60 so far during the day.

The stock hit a 52-week high of Rs 124.80 on 12 January 2017. The stock hit a 52-week low of Rs 65.85 on 19 August 2016. The stock had underperformed the market over the past 30 days till 10 March 2017, sliding 6.57% compared with the 2.18% rise in the Sensex. The scrip also underperformed the market in past one quarter, falling 5.38% as against Sensexs 8.22% gain.

The mid-cap company has equity capital of Rs 328.96 crore. Face value per share is Rs 10.

IL&FS Transportation Networks had entered into share purchase agreement on 24 August 2016 with Cube Highways & Infrastructure Pte., a company incorporated in Singapore for sale of its entire equity stake in Andhra Pradesh Expressway for an aggregate value of Rs 140.37 crore.

IL&FS Transportation Networks reported net profit of Rs 55.66 crore in Q3 December 2016 as against net loss of Rs 19.42 crore in Q3 December 2015. Net sales dropped 23.8% to Rs 763 crore in Q3 December 2016 over Q3 December 2015.

IL&FS Transportation Networks has grown into the largest BOT (build, operate and transfer) road assets owner in India.

Powered by Capital Market - Live News

Scan Steels allots 10,13,332 equity shares
Mar 14,2017

Scan Steels announced that the Company on 14 March 2017 has issued and allotted 10,13,332 Equity Shares of Rs. 10/- each, upon conversion of warrants.

Consequently, with effect from 14 March 2017, the Issued, Subscribed and Paid-up Equity Share Capital of the Company stands increased to Rs. 51,55,22,950/- divided into 5,15,52,295 Equity Shares of Re. 10/- each.

Powered by Capital Market - Live News

Graviss Hospitality announces demise of director
Mar 14,2017

Graviss Hospitality announced the sad demise of R. K. P. Sankardass, Independent Director of the Company, on 11 March 2017.

Powered by Capital Market - Live News

Board of Overseas Synthetics approves change in company secretary
Mar 14,2017

Overseas Synthetics announced that Ishwar Nayi has resigned from the office of Company Secretary & Compliance Officer of the Company w.e.f. 14 March 2017. Also, the Board of Directors in its Meeting held on 14 March 2017 has appointed Dharmesh Vankar. who is a qualified Company Secretary, as the Company Secretary & Compliance Officer of the Company w.e.f. 15 March 2017

Powered by Capital Market - Live News

Amulya Leasing & Finance to hold EGM
Mar 14,2017

Amulya Leasing & Finance announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 15 April 2017 .

Powered by Capital Market - Live News

Vikas Wsp to hold board meeting
Mar 14,2017

Vikas Wsp will hold a meeting of the Board of Directors of the Company on 21 March 2017, to fix a price of an equity share as per SEBI guidelines to allot fresh equity shares on preferential basis to perospective investors other than promoters

Powered by Capital Market - Live News

Gitanjali Gems jumps after subsidiary files for IPO
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 482.34 points, or 1.67% to 29,428.57.

On the BSE, 1.85 lakh shares were traded in the counter so far, compared with average daily volumes of 3.06 lakh shares in the past one quarter. The stock had hit a high of Rs 68.65 and a low of Rs 66.25 so far during the day. The stock hit a 52-week high of Rs 93.60 on 10 October 2016. The stock hit a 52-week low of Rs 31.55 on 18 March 2016.

The stock had underperformed the market over the past one month till 10 March 2017, falling 12.80% compared with 2.18% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 5.41% as against Sensexs 8.22% rise.

The small-cap company has equity capital of Rs 118.62 crore. Face value per share is Rs 10.

Gitanjali Gems announced that Nakshatra World (NWL) (formerly known as Gitanjali Brands), a wholly-owned subsidiary of the company, has filed its draft red herring prospectus dated 8 March 2017, for an initial public offering (IPO) with the Securities and Exchange Board of India (Sebi) as well as with both the stock exchanges i.e. BSE and National Stock Exchange of India.

On a consolidated basis, net profit of Gitanjali Gems declined 23.62% to Rs 57.63 crore on 1.37% decline in net sales to Rs 3352.97 crore in Q3 December 2016 over Q3 December 2015.

Gitanjali Gems is engaged in diamond cutting and polishing, and diamond and gold jewelry manufacturing.

Powered by Capital Market - Live News

Palred Technologies to hold EGM
Mar 14,2017

Palred Technologies announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 8 April 2017 .

Powered by Capital Market - Live News

Pennar Industries secures new orders
Mar 14,2017

Pennar Industries has received orders worth Rs 202 crore across its business units including railway products, solar products, precision tubes, industrial components, steel products, defence products and engineering services division.

Powered by Capital Market - Live News

Board of Denis Chem Lab allots 27 lakh shares on conversion of equity warrants
Mar 14,2017

Denis Chem Lab announced that the Board of Directors of the Company in their meeting held on 14 March 2017 has allotted 27,00,000 Equity Shares of Rs. 10/- each @ premium of Rs. 50/- per Equity Share to Non-Promoters of the Company on Preferential basis upon conversion of 27,00,000 Equity Warrants of Rs.10/- each @ premium of Rs. 50/- per Equity Warrant.

Powered by Capital Market - Live News